Background Image
Biomet
One Surgeon. One Patient.
 
 

Connections : Join the Conversation - The blog of Biomet CEO Jeffrey R. Binder

24
Jun

The value of medical technology companies in a competitive environment

Posted: Jun-24-2011 11:56 AM ET  |  Add Comment  |  Comments (2)

Share/Bookmark Subscribe to RSS Feed

Part 1: macroeconomic benefits

Introduction

The world's healthcare systems seem to be of two minds regarding medical technology and the companies that provide it. While generally acknowledging the benefits of advancing medical technology, governments, payors, and academics also reflexively point to medical technology as a driver of escalating healthcare costs, prompting policies to incentivize reduced waste and utilization.

Healthcare systems in all countries are justifiably concerned about improving the value delivered by healthcare spending. Yet their focus has been overwhelmingly on reducing the cost of medical technology, probably because supply costs are relatively easy to identify and squeeze, whereas efficiency and quality improvements are harder to measure and implement.

In the urgency to reduce costs, the value that medical technology companies deliver is generally overlooked or under-emphasized.

The next three blogs will attempt to provide balance to the discussion by exploring the economic benefits that accrue from medical device innovation. These benefits include the creation of jobs and economic growth, which is explored in this installment. Subsequent blogs will examine how medical device technology generates economic benefits to healthcare systems, and how a highly competitive market ensures reasonable pricing for devices.

A profile of the medical device industry

Every country is looking to promote innovative businesses in growing markets that create well-paying jobs. Medical device manufacturers demonstrate all these characteristics.

The world's medical device industry is comprised of over 27,000 medical device companies,1, 2 employing almost one million people2,3 and generating over $233 billion in global revenue.4 Europe employs over half of the world's medical technology workers in 22,500 companies.2 The leading markets for these devices are the Americas and Western Europe.4 Forty percent of revenue is generated in the United States, by far the largest single-country market for medical devices.4



Source: The World Medical Markets Fact Book 2010.

The device industry is also growing, far exceeding global GDP growth from 2004-09.4,5



Source: The World Medical Markets Fact Book 2010; World Bank Global Economic Monitor Database.

The medical device industry is one of the few industries that have created jobs despite challenging global economic conditions. For example, in the U.S., the world's largest medical device market, employment in the medical device industry grew 12.5% between 2005 and 20083 as compared to general employment growth of 2.6% in the U.S. and 3.9% in OECD member countries.6

Nonetheless, the U.S. device industry was not immune from the effects of recession. Employment in the U.S. device industry declined 1.1% in 2008, a far slower rate of decline than all U.S. manufacturing, which shed nearly 5% of its jobs.3

Additionally, in the U.S., each job has a multiplier effect, supporting an additional 1.5 jobs as a result of the companies' economic activity and spending of their employees. Thus, every new job in the medical device industry is actually the equivalent of 2.5 jobs.3 Assuming this ratio holds throughout the world, the global medical device industry supports a total of approximately 2.5 million jobs.1,2,3

Further, the jobs in the medical device industry pay well compared to other jobs. For example, in 2008, the average annual wages per worker in the U.S. medical device industry was 38% higher than the average for all U.S. workers.3



Source: Lewin Group, June 7, 2010

In short, the global medical device industry is an important and productive employer and generator of growing revenue-exactly what the world's economies are looking for.

Research investments

Medical device companies are also an important source of research and development funding. In the U.S., for example, medical device companies have expanded research spending faster than other entities, including the pharmaceutical industry.7



Source: Dorsey, et al., "Funding of U.S. Biomedical Research, 2003-2008," JAMA, January 13, 2010.

Conclusion

The medical device industry is a highly competitive, growing industry, providing well-paying jobs to one million workers worldwide, and supporting jobs for another 1.5 million. In a global economy wracked by recession, the medical device industry emerged as one of the bright spots.

However, this very track record of success is, to some observers, part of the problem of rising healthcare expenses. The question is whether spending on medical devices delivers value to the world's patients and healthcare systems. I'll explore that topic in the next blog.

References
  1. Linehan, J.H., Pietzsch, J.B., "A Comprehensive Analysis of the FDA 510(k) Process: Industry Practice and the Implications for Reform," National Press Club, Washington DC, May 24, 2011, available at http://www.inhealth.org/
  2. Coudray A.C., "Innovation in medical technology as a response to Europe's healthcare challenges-industry's viewpoint," Eucomed, presented March 22, 2011, available at www.eucomed.org.
  3. "State Economic Impact of the Medical Technology Industry," The Lewin Group, June 7, 2010, available at http://www.socalbio.org/studies/MTI_Lewin_2010.pdf.
  4. "The World Medical Markets Fact Book 2010," Espicom Business Intelligence, 2010.
  5. World Bank Global Economic Monitor, available at http://data.worldbank.org/data-catalog/global-economic-monitor.
  6. "Main Economic Indicators (MEI): Labour Force Statistics," Organisation of Economic Cooperation and Development, available at http://stats.oecd.org/index.aspx?querytype=view&queryname=213.
  7. Dorsey, E.R., et al., "Funding of U.S. Biomedical Research, 2003-2008," JAMA, January 13, 2010, available at http://jama.ama-assn.org/content/303/2/137.short

2 Comments to The value of medical technology companies in a competitive environment


The opinions expressed in the comments section of this blog are solely those of the commenter.
Submitted: Aug-10-2011 4:41 PM ET by Sandeepan Dutta
I am amazed by the numbers shown in the blog. It does look like medical device industry is creating jobs and has added to the world economy. However, it does seem like the industry has slow growth in terms of new products. This area has been given generous investments (which does pay the salary of all the employees). Biomet has taken over many companies itself, but it does not look like there has been introduction of new ideas in the field. To put it in simple words, this field is growing and giving jobs to many employees, but new products and new ideas seem stagnant.

Submitted: Feb-29-2012 2:42 AM ET by Dr. Markus Haller
This topic makes one think about which direction this all will take over the next few years; in particular the clear notion that healthcare "costs" continue to increase.

How can we as medical device maker influence this direction ?

More Incentives should be made available to device makers, that focus on overall "cost-to-the-system" reductions. FDA is only focused of safety and efficacy, but at the end the products also need to be justified in the eyes of those, that have to pay for them.

I spent a week at the AAOS and found that not very much had changed since the show in 2011, while I found some companies, like Biomet, are at the forefront solid new product categories, investing their hard earned profits into driving medical innovation.

On the other hand, I am sure that the general lack of new products, is not due to a lack of great and innovative product ideas, but more due challenges to get those product ideas in the respective markets at reasonable costs..

Globally, governments should put more programs in place, including fast-tracks through FDA and other respective regulatory agencies, that would clearly "self-finance", based on the notion that projects in this program, would significantly reduce overall cost - by potentially changing medical practice based on innovative products.

Changes is medical practice is what made many innovative products successful in the past. Just think about how heart patients were treated before pacemakers, deaf people before cochlear implants and how general anesthesia was made possible with endotracheal tubes, and of course patients facing the wheelchairs in agony prior to orthopedic implants., etc.

I have been facing those challenges during my entire career, and do so once again with one of my current projects. Its about an orthopedic surgical tool, that will take a lot of ambiguity out of the surgical procedures and hence improve outcomes, while reducing overall cost, however, it will need the acceptance of the medical practitioners, just like any other new product.


Add Your Comment


Comments are moderated by Biomet, and may not appear on this blog until they have been reviewed and deemed appropriate for posting.

Policy on posting comments
The goal of "Connections" is to encourage informed discussion on issues that affect our community. The blog is moderated—all comments will be reviewed prior to posting. Our rules for posting comments are:

  1. Comments must be relevant to the topic at hand.
  2. Dissenting points of view are welcome. However, comments must contribute to a civil discourse—inflammatory and insulting comments will not be posted.
  3. Comments will not be edited. They will either be accepted or rejected in full.

Please do not ask general questions about Biomet in the comments section—we will not respond through this site. If you have questions for Biomet, please click here for contact information. The comments section of this blog is for comments related to the blog content only.

Name:
(required)
Email Address:
(required, not displayed)
Comment:
(required)
 


© Copyright 2013 Biomet, Inc. All rights reserved.
Background Image